Blinfant protocol: Pilot study - the addition of Blinatumomab to the Interfant-06 backbone in infants with MLL-rearranged acute lymphoblastic leukaemia

report

posted on 2020-12-08, 03:53 authored by Janelle JonesJanelle Jones

Protocol summary

History

Usage metrics

Categories

Cancer therapy (excl. chemotherapy and radiation therapy)

Keywords

Acute lymphoblastic leukemia Infant Clinical Trial Randomization Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

Exports